PRICE T ROWE ASSOCIATES INC /MD/
Position in LGND — Ligand Pharmaceuticals Inc
CIK 80255
BALTIMORE, MD
Position in LGND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,915,280
+$24,143,446 QoQ
Shares Held
91,478
+282.7% QoQ
Ownership
0.459%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,929,584,838 across 304 Biotechnology names. LGND ranks #83 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | TWST |
Twist Bioscience Corp
|
3,634,652 | $373,932,997 |
All Filings in LGND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,915,280 | 91,478 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,771,834 | 23,901 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,779,886 | 19,992 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,350,602 | 18,915 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,038,401 | 17,968 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,714,622 | 16,308 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,662,753 | 15,518 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,374,936 | 13,737 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,142,064 | 13,591 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $949,714 | 12,992 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $881,682 | 12,382 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $688,184 | 11,522 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $751,137 | 10,418 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $704,925 | 9,583 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $567,532 | 8,496 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $712,732 | 8,277 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $623,915 | 6,993 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $914,319 | 8,128 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,158,758 | 7,502 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,218,492 | 8,746 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,228,725 | 9,366 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,561,849 | 10,245 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $6,346,697 | 63,818 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $16,824,073 | 176,501 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $33,119,222 | 296,104 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $23,293,794 | 320,322 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||